Skip to content

Constipation Fiber Trial

Double-blind, Placebo-controlled Study to Examine the Effects of Dietary Fiber in Treating Childhood Constipation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02193997
Enrollment
60
Registered
2014-07-18
Start date
2012-06-30
Completion date
2014-07-31
Last updated
2017-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation in Children

Brief summary

This study examines the effects of dietary fiber in the treatment of functional childhood constipation.

Detailed description

This is a 4-week double-blind, placebo-controlled study to examine the effects of dietary fiber in treating functional childhood constipation. The addition of fiber is anticipated to allow children to have more normal stool consistency and frequency. All participants will be asked to take a snack bar twice daily and will be randomized in a 1:1:1 ratio to fiber 1, fiber 2 or placebo snack bar groups. All participants will be asked to take low-dose Miralax to avoid worsening of constipation in all groups.

Interventions

OTHERFiber
OTHERPlacebo

Sponsors

Warren Bishop
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
2 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* 2-16 years of age with functional constipation as defined based on the Rome III criteria

Exclusion criteria

* Constipation attributable to organic and anatomic causes or intake of medication * Children who had previous surgery of the colon or anus * History of allergy/intolerance to components of snack bar (e.g. celiac disease)

Design outcomes

Primary

MeasureTime frameDescription
Change in stool frequency4 weeks
Change in stool consistency4 weeksStool consistency (using the Bristol scale) will be compared between groups, between baseline and study end

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026